Sort   by:  
 Page size 
UnknownIdentification of IGF2 as Genomic Driver and Actionable Therapeutic Target in Hepatoblastoma.
Not available
S-EPMC10073300 | biostudies-literature
UnknownImmunomodulatory Effects of Lenvatinib Plus Anti-Programmed Cell Death Protein 1 in Mice and Rationale for Patient Enrichment in Hepatocellular Carcinoma.
Not available
S-EPMC12155127 | biostudies-literature
UnknownMultiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.
Not available
S-EPMC7615263 | biostudies-literature
UnknownSelective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy.
Not available
S-EPMC6934184 | biostudies-literature
UnknownCross-ancestry genome-wide association analysis of corneal thickness strengthens link between complex and Mendelian eye diseases.
Not available
S-EPMC5951816 | biostudies-literature
UnknownPost-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Not available
S-EPMC10789589 | biostudies-literature
UnknownLong term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
Not available
S-EPMC11743801 | biostudies-literature
UnknownCohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study.
Not available
S-EPMC10859139 | biostudies-literature
UnknownBiallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections.
Not available
S-EPMC10932913 | biostudies-literature
UnknownPrevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
Not available
S-EPMC10005893 | biostudies-literature
Sort   by:  
 Page size